BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30538373)

  • 21. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of metastatic disease to the liver.
    Arciero CA; Sigurdson ER
    Semin Oncol; 2008 Apr; 35(2):147-59. PubMed ID: 18396200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case.
    Arata R; Itamoto T; Ikeda S; Nakahara H; Oshita A; Shinozaki K; Nishisaka T
    Surg Case Rep; 2016 Dec; 2(1):106. PubMed ID: 27686666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locoregional strategies for colorectal hepatic metastases.
    Meyers MO; Sasson AR; Sigurdson ER
    Clin Colorectal Cancer; 2003 May; 3(1):34-44. PubMed ID: 12777190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial hepatic artery infusion and systemic chemotherapy for asymptomatic colorectal cancer with un-resectable liver metastasis.
    Shi L; Zhao J; Lu Q; Chen X; Wang H; Jiang Y; Wu J; Ji M; Xu B; Chen L; Jiang J; Wu C
    Int J Clin Exp Med; 2015; 8(1):1000-8. PubMed ID: 25785086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adjuvant chemotherapy in liver malignancy for improving operability].
    Kubicka S; Manns MP
    Chirurg; 2001 Jul; 72(7):759-64. PubMed ID: 11490752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer.
    Osada S; Imai H; Sasaki Y; Tanaka Y; Matsuhashi N; Okumura N; Nagase M; Nonaka K; Yoshida K
    Oncol Rev; 2012 Mar; 6(1):e9. PubMed ID: 25992211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of synchronous colorectal liver metastases].
    Dupré A; Gagnière J; Chen Y; Rivoire M
    Bull Cancer; 2013 Apr; 100(4):363-71. PubMed ID: 23559319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
    Kingham TP; D'Angelica M; Kemeny NE
    J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.
    Kennedy A; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kaiser A; Nutting CW; Rose SC; Wang EA; Savin MA
    J Gastrointest Oncol; 2017 Aug; 8(4):614-624. PubMed ID: 28890810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of colorectal cancer with synchronous bilobar liver metastases with simultaneous bowel and liver resection plus radiofrequency ablation.
    Julianov A; Karashmalakov A; Rachkov I; Hristov H
    Hepatogastroenterology; 2004; 51(57):643-5. PubMed ID: 15143882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.
    Bathe OF; Dowden S; Sutherland F; Dixon E; Butts C; Bigam D; Walley B; Ruether D; Ernst S
    BMC Cancer; 2004 Jul; 4():32. PubMed ID: 15245580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.
    Raval M; Bande D; Pillai AK; Blaszkowsky LS; Ganguli S; Beg MS; Kalva SP
    Front Oncol; 2014; 4():120. PubMed ID: 25120951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Perspectives in the Treatment of Colorectal Metastases.
    Elias D; Viganò L; Orsi F; Scorsetti M; Comito T; Lerut J; Cosola D; Torzilli G
    Liver Cancer; 2016 Nov; 6(1):90-98. PubMed ID: 27995093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
    Hopt UT; Drognitz O; Neeff H
    Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of chemotherapy in managing patients with resectable liver metastases.
    Halfdanarson TR; Kendrick ML; Grothey A
    Cancer J; 2010; 16(2):125-31. PubMed ID: 20404609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of resectable and unresectable liver metastases from colorectal cancer.
    Kemeny N
    Curr Opin Oncol; 2010 Jul; 22(4):364-73. PubMed ID: 20520544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of colorectal liver metastases: a review.
    Van den Eynde M; Hendlisz A
    Rev Recent Clin Trials; 2009 Jan; 4(1):56-62. PubMed ID: 19149763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.